297 related articles for article (PubMed ID: 21546258)
1. Esophageal adenocarcinoma arising after antireflux surgery: a population-based analysis.
Kauttu TM; Rantanen TK; Sihvo EI; Räsänen JV; Puolakkainen P; Salo JA
Eur J Cardiothorac Surg; 2011 Dec; 40(6):1450-4; discussion 1454. PubMed ID: 21546258
[TBL] [Abstract][Full Text] [Related]
2. [The influence of Barrett's esophagus on the clinical signs and postoperative results of GERD].
Endzinas Z; Mickevicius A; Kiudelis M
Zentralbl Chir; 2004 Apr; 129(2):99-103. PubMed ID: 15106039
[TBL] [Abstract][Full Text] [Related]
3. Does a surgical antireflux procedure decrease the incidence of esophageal adenocarcinoma in Barrett's esophagus? A meta-analysis.
Corey KE; Schmitz SM; Shaheen NJ
Am J Gastroenterol; 2003 Nov; 98(11):2390-4. PubMed ID: 14638338
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: follow-up of a randomized controlled trial.
Spechler SJ; Lee E; Ahnen D; Goyal RK; Hirano I; Ramirez F; Raufman JP; Sampliner R; Schnell T; Sontag S; Vlahcevic ZR; Young R; Williford W
JAMA; 2001 May; 285(18):2331-8. PubMed ID: 11343480
[TBL] [Abstract][Full Text] [Related]
5. Esophagitis: incidence and risk of esophageal adenocarcinoma--a population-based cohort study.
Lassen A; Hallas J; de Muckadell OB
Am J Gastroenterol; 2006 Jun; 101(6):1193-9. PubMed ID: 16771936
[TBL] [Abstract][Full Text] [Related]
6. Barrett's esophagus: the role of laparoscopic fundoplication.
Abbas AE; Deschamps C; Cassivi SD; Allen MS; Nichols FC; Miller DL; Pairolero PC
Ann Thorac Surg; 2004 Feb; 77(2):393-6. PubMed ID: 14759403
[TBL] [Abstract][Full Text] [Related]
7. Antireflux Surgery and Risk of Esophageal Adenocarcinoma: A Systematic Review and Meta-analysis.
Maret-Ouda J; Konings P; Lagergren J; Brusselaers N
Ann Surg; 2016 Feb; 263(2):251-7. PubMed ID: 26501714
[TBL] [Abstract][Full Text] [Related]
8. Barrett's esophagus in patients with gastroesophageal reflux disease. Medical therapy or antireflux surgery?
Klaus A; Mühlmann G; Kirchmayr W; Weiss H; Wetscher GJ
Minerva Chir; 2002 Aug; 57(4):397-402. PubMed ID: 12145570
[TBL] [Abstract][Full Text] [Related]
9. Surgical management of gastroesophageal reflux disease/Barrett's esophagus.
D'Cunha J; Andrade RS; Maddaus MA
Minerva Chir; 2011 Feb; 66(1):7-19. PubMed ID: 21389921
[TBL] [Abstract][Full Text] [Related]
10. Reduction of interleukin 8 gene expression in reflux esophagitis and Barrett's esophagus with antireflux surgery.
Oh DS; DeMeester SR; Vallbohmer D; Mori R; Kuramochi H; Hagen JA; Lipham J; Danenberg KD; Danenberg PV; Chandrasoma P; DeMeester TR
Arch Surg; 2007 Jun; 142(6):554-9; discussion 559-60. PubMed ID: 17576892
[TBL] [Abstract][Full Text] [Related]
11. Long-term clinical and pathologic response of Barrett's esophagus after antireflux surgery.
O'Riordan JM; Byrne PJ; Ravi N; Keeling PW; Reynolds JV
Am J Surg; 2004 Jul; 188(1):27-33. PubMed ID: 15219481
[TBL] [Abstract][Full Text] [Related]
12. Gastroesophageal reflux disease as a cause of death is increasing: analysis of fatal cases after medical and surgical treatment.
Rantanen TK; Sihvo EI; Räsänen JV; Salo JA
Am J Gastroenterol; 2007 Feb; 102(2):246-53. PubMed ID: 17156140
[TBL] [Abstract][Full Text] [Related]
13. Adenocarcinoma of the Oesophagus and Oesophagogastric Junction: Analysis of Incidence and Risk Factors.
Rantanen T; Oksala N; Sand J
Anticancer Res; 2016 May; 36(5):2323-9. PubMed ID: 27127139
[TBL] [Abstract][Full Text] [Related]
14. Differential molecular changes in patients with asymptomatic long-segment Barrett's esophagus treated by antireflux surgery or medical therapy.
Babar M; Ennis D; Abdel-Latif M; Byrne PJ; Ravi N; Reynolds JV
Am J Surg; 2010 Feb; 199(2):137-43. PubMed ID: 19306979
[TBL] [Abstract][Full Text] [Related]
15. [Barrett's oesophagus: place of antireflux surgery].
Mabrut JY; Baulieux J
Ann Chir; 2006 Mar; 131(3):177-82. PubMed ID: 16527242
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for esophageal adenocarcinoma after antireflux surgery.
Löfdahl HE; Lu Y; Lagergren P; Lagergren J
Ann Surg; 2013 Apr; 257(4):579-82. PubMed ID: 23426349
[TBL] [Abstract][Full Text] [Related]
17. The impact of antireflux surgery on oxidative stress of esophageal mucosa caused by gastroesophageal reflux disease: 4-yr follow-up study.
Rantanen TK; Räsänen JV; Sihvo EI; Ahotupa MO; Färkkilä MA; Salo JA
Am J Gastroenterol; 2006 Feb; 101(2):222-8. PubMed ID: 16454822
[TBL] [Abstract][Full Text] [Related]
18. Adenocarcinoma in Barrett's esophagus after elimination of gastroesophageal reflux.
Hamilton SR; Hutcheon DF; Ravich WJ; Cameron JL; Paulson M
Gastroenterology; 1984 Feb; 86(2):356-60. PubMed ID: 6690363
[TBL] [Abstract][Full Text] [Related]
19. KTP laser ablation of Barrett's esophagus after anti-reflux surgery results in long-term loss of intestinal metaplasia. Potassium-titanyl-phosphate.
Bowers SP; Mattar SG; Waring PJ; Galloway K; Nasir A; Pascal R; Hunter JG
Surg Endosc; 2003 Jan; 17(1):49-54. PubMed ID: 12364985
[TBL] [Abstract][Full Text] [Related]
20. Gastroesophageal reflux disease, proton-pump inhibitor use and Barrett's esophagus in esophageal adenocarcinoma: Trends revisited.
Lada MJ; Nieman DR; Han M; Timratana P; Alsalahi O; Peyre CG; Jones CE; Watson TJ; Peters JH
Surgery; 2013 Oct; 154(4):856-64; discussion 864-6. PubMed ID: 24074425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
